Comparison of Short Versus 12 Months Prasugrel Plus Aspirin in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention and Everolimus-eluting Stents

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 130 participants.

Also called NCT06718179

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 130 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06718179
  • EU CT 2024-515236-69-00
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT06718179. Randomized; single masking; primary purpose treatment. Start 2024-11-16 (actual); primary completion 2025-05-25 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Short Versus 12 Months Prasugrel Plus Aspirin in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention and Everolimus-eluting Stents
Acronym
SORT OUT DAPT
Condition
Acute Coronary Syndrome
Intervention (Drug)
Short duration of aspirin and prasugrel
Intervention (Drug)
Conventional duration of aspirin and prasugrel
Lead sponsor
Odense University Hospital (class: other)

Record details

Record id
cardio:ct-nct06718179
Content hash
01af1d4ff937adfb7efc98eee91a49e9ad3bc9778b47c8466a3273625242864d